EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genotype–phenotype associations in 1018 individuals with SCN1A ‐related epilepsies

Declan Gallagher iD, Eduardo Pérez-Palma, Tobias Bruenger, Ismael Ghanty, Eva Brilstra, Berten Ceulemans, Nicole Chemaly, Iris de Lange iD, Christel Depienne iD, Renzo Guerrini, Davide Mei iD, Rikke S Møller iD und 10 weitere

Epilepsia · 2024-04 · 65 (4) · 1046-1059

DOI: 10.1111/epi.17882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, online erschienen am 27.02.2024. Verfasst von Declan Gallagher und 21 weiteren Autor:innen. Beteiligte Einrichtung: School of Health and Wellbeing, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Epilepsy, Epilepsies, Myoclonic, Seizures, Febrile, Status Epilepticus. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dravet Syndrome UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

SCN1A variants are associated with epilepsy syndromes ranging from mild genetic epilepsy with febrile seizures plus (GEFS+) to severe Dravet syndrome (DS). Many variants are de novo, making early phenotype prediction difficult, and genotype–phenotype associations remain poorly understood.

Methods

We assessed data from a retrospective cohort of 1018 individuals with SCN1A‐ related epilepsies. We explored relationships between variant characteristics (position, in silico prediction scores: Combined Annotation Dependent Depletion (CADD), Rare Exome Variant Ensemble Learner (REVEL), SCN1A genetic score), seizure characteristics, and epilepsy phenotype.

Results

DS had earlier seizure onset than other GEFS+ phenotypes (5.3 vs. 12.0 months, p < .001). In silico variant scores were higher in DS versus GEFS+ ( p < .001). Patients with missense variants in functionally important regions (conserved N‐terminus, S4–S6) exhibited earlier seizure onset (6.0 vs. 7.0 months, p = .003) and were more likely to have DS (280/340); those with missense variants in nonconserved regions had later onset (10.0 vs. 7.0 months, p = .036) and were more likely to have GEFS+ (15/29, χ 2 = 19.16, p < .001). A minority of protein‐truncating variants were associated with GEFS+ (10/393) and more likely to be located in the proximal first and last exon coding regions than elsewhere in the gene (9.7% vs. 1.0%, p < .001). Carriers of the same missense variant exhibited less variability in age at seizure onset compared with carriers of different missense variants for both DS (1.9 vs. 2.9 months, p = .001) and GEFS+ (8.0 vs. 11.0 months, p = .043). Status epilepticus as presenting seizure type is a highly specific (95.2%) but nonsensitive (32.7%) feature of DS. Significance Understanding genotype–phenotype associations in SCN1A ‐related epilepsies is critical for early diagnosis and management. We demonstrate an earlier disease onset in patients with missense variants in important functional regions, the occurrence of GEFS+ truncating variants, and the value of in silico prediction scores. Status epilepticus as initial seizure type is a highly specific, but not sensitive, early feature of DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpilepsyEpilepsies, MyoclonicSeizures, FebrileStatus EpilepticusHumansRetrospective StudiesNAV1.1 Voltage-Gated Sodium ChannelPhenotypeGenetic Association StudiesMutation

Stichwörter der Autor:innen

SCN1ADravet syndromeGEFS+genotype–phenotype associationssevere myoclonic epilepsy of infancy

Substanzen

NAV1.1 Voltage-Gated Sodium ChannelSCN1A protein, human

Autor:innen und Institutionen

  • School of Health and Wellbeing, University of Glasgow, Glasgow, UK.
  • Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
  • Universidad del Desarrollo, Centro de Genética y Genómica, Facultad de Medicina Clínica Alemana, Santiago, Chile.
  • Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Department of Genetics, University Medical Center, Utrecht, the Netherlands.
  • Department of Child Neurology, University Hospital Antwerp, Antwerp, Belgium.

ORCID-Profile: Declan Gallagher, Iris de Lange, Christel Depienne, Davide Mei, Rikke S Møller, Rima Nabbout, Amy L Schneider, Ingrid E Scheffer, An-Sofie Schoonjans, Sameer M Zuberi, Dennis Lal, Andreas Brunklaus

Förderung

  • Dravet Syndrome UK

Zitieren

APA

Gallagher, D., Pérez-Palma, E., Bruenger, T., Ghanty, I., Brilstra, E., Ceulemans, B., Chemaly, N., de Lange, I., Depienne, C., Guerrini, R., Mei, D., Møller, R. S., Nabbout, R., Regan, B. M., Schneider, A. L., Scheffer, I. E., Schoonjans, A. S., Symonds, J. D., Weckhuysen, S., …, & Brunklaus, A. (2024). Genotype–phenotype associations in 1018 individuals with SCN1A ‐related epilepsies. Epilepsia, 65(4), 1046-1059. https://doi.org/10.1111/epi.17882

Vancouver

Gallagher D, Pérez-Palma E, Bruenger T, Ghanty I, Brilstra E, Ceulemans B, et al. Genotype–phenotype associations in 1018 individuals with SCN1A ‐related epilepsies. Epilepsia. 2024;65(4):1046-1059. doi:10.1111/epi.17882

BibTeX
@article{Gallagher2024,
  author = {Gallagher, Declan and Pérez-Palma, Eduardo and Bruenger, Tobias and Ghanty, Ismael and Brilstra, Eva and Ceulemans, Berten and Chemaly, Nicole and de Lange, Iris and Depienne, Christel and Guerrini, Renzo and Mei, Davide and Møller, Rikke S and Nabbout, Rima and Regan, Brigid M and Schneider, Amy L and Scheffer, Ingrid E and Schoonjans, An-Sofie and Symonds, Joseph D and Weckhuysen, Sarah and Zuberi, Sameer M and Lal, Dennis and Brunklaus, Andreas},
  title = {Genotype–phenotype associations in 1018 individuals with SCN1A ‐related epilepsies},
  journal = {Epilepsia},
  year = {2024},
  volume = {65},
  number = {4},
  pages = {1046--1059},
  doi = {10.1111/epi.17882}
}
Kostenlos starten →